Kathleen Tulley, Editorial Director

RVT-101 improved cognition and function when combined with donepezil in patients with mild to moderate Alzheimer’s disease.

Investigators identified a possible disease-modifying effect of solanezumab as an early treatment for Alzheimer’s disease, but the benefit in clinical practice remains unclear.